Amaryl and Travatan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amaryl (glimepiride) and Travatan (travoprost). Common drug interactions include hyperhidrosis among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Amaryl and Travatan. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.

What is Travatan?

Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.



On Aug, 06, 2026

33 people who take Amaryl and Travatan together, and have interactions are studied.

Amaryl and Travatan drug interactions.

What are the common drug interactions of Amaryl and Travatan, by gender? *:

female:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Hypersensitivity
  3. Limb injury
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Nausea (feeling of having an urge to vomit)
  6. Nervousness
  7. Pain in extremity
  8. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  10. Rhinorrhoea (watery mucus discharge from the nose)

male:

  1. General physical health deterioration (weak health status)
  2. Blood alkaline phosphatase increased
  3. Urinary tract infection
  4. Cough
  5. Pyrexia (fever)
  6. Back pain
  7. Dehydration (dryness resulting from the removal of water)
  8. Depressed mood
  9. Loss of employment
  10. Mood swings (an extreme or rapid change in mood)

What are the common drug interactions of Amaryl and Travatan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back pain
  2. Dehydration (dryness resulting from the removal of water)
  3. Depressed mood
  4. Loss of employment
  5. Mood swings (an extreme or rapid change in mood)
  6. Blood alkaline phosphatase increased
  7. Blood creatinine increased
  8. General physical health deterioration (weak health status)
  9. Herpes zoster
  10. Neutropenia (an abnormally low number of neutrophils)

40-49:

n/a

50-59:

n/a

60+:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Activities of daily living impaired
  3. Cerebral infarction (less blood supply to brain resulting tissue damage)
  4. Chronic kidney disease
  5. Colitis (inflammation of colon)
  6. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  7. Depressed level of consciousness
  8. Diarrhoea
  9. Dizziness
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 14 people, 42.42%
  2. High Blood Pressure: 8 people, 24.24%
  3. Urinary Tract Infection: 4 people, 12.12%
  4. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 4 people, 12.12%
  5. High Blood Cholesterol: 4 people, 12.12%
  6. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 3 people, 9.09%
  7. Asthma: 2 people, 6.06%
  8. Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 2 people, 6.06%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 6.06%
  10. Gastric Ph Decreased: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Amaryl and Travatan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amaryl and Travatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Travatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amaryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Travatan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride and travoprost (the active ingredients of Amaryl and Travatan, respectively), and Amaryl and Travatan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: